Infanrix-IPV/Hib Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Infanrix-IPV/Hib Vaccine, covering 2019-07-19 to 2019-07-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia [Phase 3]